Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/19/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Gordon Vehar?

Gordon A. Vehar

Vice President of Research

Genentech , Inc.

HQ Phone:  (650) 225-1000

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Genentech , Inc.

1 DNA Way

South San Francisco, California,94080

United States

Company Description

Founded more than 30 years ago, Genentech (gene.com) is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life threatening medical conditions. The company, a member of the Roch...more

Background Information

Employment History

Vice President of Research

BioMarin Pharmaceutical Inc.


Vice President of Research

Raven Biotechnologies , Inc.


Affiliations

Nobel-Pauling

Board Member


Actokine Therapeutics

Scientific Advisory Board Member


Oklahoma Center for Molecular Medicine

Scientific Advisory Board


Education

Ph. D.

University of Cincinnati Medical School


Web References(48 Total References)


Nobel Pauling Biotech Symposium - Who's who

nobel-pauling.org [cached]

Dr. Gordon Vehar PhD, VP of Research, former Genentech


Student Vision

studentvision.org [cached]

Another mentor, Dr. Gordon Vehar at Genentech, taught me to be more conservative scientist and taught me to stay focused on in vivo efficacy.
After advancing a preclinical project to development with Gordon in two years, I felt like a sapling stretching towards the sky and decided that it was finally time to leave home like a little bird exploring the world.


Actokine Therapeutics

actokine.com [cached]

Dr. Grace successfully shepherded basic research discoveries to product development at Genentech with Dr. Gordon Vehar.


Nobel Pauling Biotech Symposium - Who's who

www.nobel-pauling.org [cached]

Dr. Gordon Vehar PhD, VP of Research, former Genentech


Actokine Therapeutics

www.actokine.com [cached]

Gordon Vehar, PhD, former Genentech.
Gordon Vehar, PhD., former Genentech Dr. Vehar received his PhD from the University of Cincinnati Medical School and did his postdoctoral work with Dr. Earl Davie at the University of Washington, Seattle. During his 20 years at Genentech, Dr. Vehar served various leadership functions, including Director, Cardiovascular Research, and project team leader for the Factor VIII (Kogenate, tPA (Activase, TNKase (TNKase, and Lymphotoxin Projects, as well as Staff Scientist in the Cardiovascular Research and Protein Chemistry Departments. Dr. Vehar is co-inventor on 36 issued U.S. patents and has authored more than 35 scientific publications. He has been awarded the Murray Thelin Award for Outstanding Research (1987) presented by the National Hemophilia Foundation, the Inventor of the Year Award from the Intellectual Property Owners, Inc. (1989) for the recombinant tissue plasminogen activator patent and the Distinguished Inventor of the Year Award from the Intellectual Property Owners, Inc (1999) for the recombinant factor VIII patent. He served on the Scientific Advisory Board for the Oklahoma Center for Molecular Medicine (1992-1996). Dr. Vehar joined Raven Biotechnologies in 2000, as Vice President, Research and Development. Dr. Pennica, together with Dr. Bill Kohr, Dr. David Goeddel and Dr. Gordon Vehar, made a very important heart attack drug (tissue plasminogen activator t-PA, Activase) for Genentech.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory